Apple, Inc AAPL
S&P 500 ETF Trust SPDR SPY
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

Cadrenal Therapeutics, Inc. Common Stock Share Price

CVKD

NAQ

$5.535

+$0.12

(2.21%)

Industry: Biotechnology Sector: Health Care

Cadrenal Therapeutics, Inc. Common Stock Analyst Forecast

Overview Returns Financials Ratios News FAQs

Cadrenal Therapeutics, Inc. Common Stock Share Price Chart

Cadrenal Therapeutics, Inc. Common Stock Key Stock Metrics

Market Cap info-icon

This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.

$12.67M

P/E Ratio

This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.

Volume

This is the total number of shares traded during the most recent trading day.

7.87K

Avg Volume info-icon

This is the average number of shares traded during the most recent 30 days.

Dividend Yield info-icon

This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).

0.00%

Beta

This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.

1.21

52-week Range info-icon

This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

$5.34 L

$22.9 H

$5.535

About Cadrenal Therapeutics, Inc. Common Stock, Common Stock

Cadrenal Therapeutics, Inc. operates as a late-stage biopharmaceutical company focuses on developing therapeutics for rare cardiovascular conditions. The company is developing Tecarfarin, a novel oral and reversible anticoagulant to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation, such as patients with left ventricular assist devices, end-stage kidney disease, atrial fibrillation, and thrombotic anti-phospholipid syndrome. It has a collaboration agreement with Abbott Global Enterprises Limited to evaluate the efficacy and safety of Tecarfarin in patients with a left-ventricular assist device. The company was incorporated in 2022 and is headquartered in Ponte Vedra, Florida. more

Industry: BiotechnologySector: Health Care

Cadrenal Therapeutics, Inc. Common Stock Stock Returns

Time Frame	CVKD	Sector	S&P500
1-Week Return	-2.89%	-1.08%	-1.38%
1-Month Return	-36.16%	-0.47%	-1.81%
3-Month Return	-52.49%	2.13%	1.38%
6-Month Return	-52.61%	17.04%	5.68%
1-Year Return	-71.16%	6.56%	11.74%
3-Year Return	-81.36%	16.78%	65.15%
5-Year Return	-91.04%	34.34%	73.68%

Time Frame	CVKD	Sector	S&P500
1-Week Return	-78.33%	-43.23%	-51.55%
1-Month Return	-99.57%	-5.57%	-19.93%
3-Month Return	-95.11%	8.92%	5.72%
6-Month Return	-78.00%	37.58%	11.85%
1-Year Return	-71.16%	6.56%	11.74%
3-Year Return	-42.88%	5.31%	18.20%
5-Year Return	-38.27%	6.08%	11.67%

Cadrenal Therapeutics, Inc. Common Stock Financials

	Dec '22	Dec '23	Dec '24
Total Revenue	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue	1.27K	1.98K	1.88K	[{"date":"2022-12-31","value":63.94,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":94.95,"profit":true}]
Gross Profit	(1.27K)	(1.98K)	(1.88K)	[{"date":"2022-12-31","value":-126600,"profit":false},{"date":"2023-12-31","value":-198000,"profit":false},{"date":"2024-12-31","value":-188000,"profit":false}]
Gross Margin	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]

Operating Expenses	2.70M	7.63M	10.96M	[{"date":"2022-12-31","value":24.64,"profit":true},{"date":"2023-12-31","value":69.64,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income	(2.70M)	(7.63M)	(10.96M)	[{"date":"2022-12-31","value":-270163000,"profit":false},{"date":"2023-12-31","value":-763284300,"profit":false},{"date":"2024-12-31","value":-1096061900,"profit":false}]
Total Non-Operating Income/Expense	-	(492.25K)	618.50K	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":-79.59,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Pre-Tax Income	(6.71M)	(8.36M)	(10.65M)	[{"date":"2022-12-31","value":-671432900,"profit":false},{"date":"2023-12-31","value":-835708600,"profit":false},{"date":"2024-12-31","value":-1065136800,"profit":false}]
Income Taxes	4.00	(165.91K)	-	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-4147875,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes	-	(8.19M)	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":-819117100,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]

Income From Continuous Operations	-	(8.36M)	(10.65M)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":-835708600,"profit":false},{"date":"2024-12-31","value":-1065136800,"profit":false}]
Income From Discontinued Operations	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income	(6.71M)	(8.36M)	(10.65M)	[{"date":"2022-12-31","value":-671432900,"profit":false},{"date":"2023-12-31","value":-835708600,"profit":false},{"date":"2024-12-31","value":-1065136800,"profit":false}]

EPS (Diluted)	(0.91)	(8.10)	(7.08)	[{"date":"2022-12-31","value":-91,"profit":false},{"date":"2023-12-31","value":-809.95,"profit":false},{"date":"2024-12-31","value":-708,"profit":false}]

	Dec '22	Dec '23	Dec '24
Total Revenue	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue	-	56.40%	(5.05%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-8.96,"profit":false}]
Gross Profit	-	56.40%	(5.05%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-8.96,"profit":false}]
Gross Margin	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]

Operating Expenses	-	182.66%	43.60%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":23.87,"profit":true}]
Operating Income	-	182.53%	43.60%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":23.89,"profit":true}]
Total Non-Operating Income/Expense	-	-	(225.65%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false}]
Pre-Tax Income	-	24.47%	27.45%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":89.12,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Income Taxes	-	(4147975.00%)	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]

Income From Continuous Operations	-	-	27.45%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Income From Discontinued Operations	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income	-	24.47%	27.45%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":89.12,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

EPS (Diluted)	-	790.05%	(12.59%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-1.59,"profit":false}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Revenue	-	2.13K	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Cost of Revenue	407.00	1.07K	5.52K	401.00	401.00	[{"date":"2024-09-30","value":7.38,"profit":true},{"date":"2024-12-31","value":19.34,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":7.27,"profit":true},{"date":"2025-09-30","value":7.27,"profit":true}]
Gross Profit	(407.00)	1.07K	(5.52K)	(401.00)	(401.00)	[{"date":"2024-09-30","value":-38.14,"profit":false},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-517.06,"profit":false},{"date":"2025-06-30","value":-37.58,"profit":false},{"date":"2025-09-30","value":-37.58,"profit":false}]
Gross Margin	-	50.00%	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]

Operating Expenses	2.46M	4.28M	3.92M	3.73M	2.73M	[{"date":"2024-09-30","value":57.5,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":91.68,"profit":true},{"date":"2025-06-30","value":87.28,"profit":true},{"date":"2025-09-30","value":63.89,"profit":true}]
Operating Income	(2.46M)	(4.28M)	(3.93M)	(3.73M)	(2.73M)	[{"date":"2024-09-30","value":-245995800,"profit":false},{"date":"2024-12-31","value":-427842800,"profit":false},{"date":"2025-03-31","value":-392797600,"profit":false},{"date":"2025-06-30","value":-373429100,"profit":false},{"date":"2025-09-30","value":-273380300,"profit":false}]
Total Non-Operating Income/Expense	104.26K	182.32K	165.19K	134.01K	96.20K	[{"date":"2024-09-30","value":57.18,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":90.61,"profit":true},{"date":"2025-06-30","value":73.5,"profit":true},{"date":"2025-09-30","value":52.76,"profit":true}]
Pre-Tax Income	(2.41M)	(4.19M)	(3.85M)	(3.67M)	(2.69M)	[{"date":"2024-09-30","value":-240782900,"profit":false},{"date":"2024-12-31","value":-418726900,"profit":false},{"date":"2025-03-31","value":-384538000,"profit":false},{"date":"2025-06-30","value":-366728700,"profit":false},{"date":"2025-09-30","value":-268570500,"profit":false}]
Income Taxes	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Income After Taxes	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]

Income From Continuous Operations	(2.41M)	(4.19M)	(3.85M)	(3.67M)	(2.69M)	[{"date":"2024-09-30","value":-240782900,"profit":false},{"date":"2024-12-31","value":-418726900,"profit":false},{"date":"2025-03-31","value":-384538000,"profit":false},{"date":"2025-06-30","value":-366728700,"profit":false},{"date":"2025-09-30","value":-268570500,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Net Income	(2.41M)	(4.19M)	(3.85M)	(3.67M)	(2.69M)	[{"date":"2024-09-30","value":-240782900,"profit":false},{"date":"2024-12-31","value":-418726900,"profit":false},{"date":"2025-03-31","value":-384538000,"profit":false},{"date":"2025-06-30","value":-366728700,"profit":false},{"date":"2025-09-30","value":-268570500,"profit":false}]

EPS (Diluted)	(2.18)	(2.55)	(2.09)	(1.87)	(1.31)	[{"date":"2024-09-30","value":-218,"profit":false},{"date":"2024-12-31","value":-255,"profit":false},{"date":"2025-03-31","value":-209,"profit":false},{"date":"2025-06-30","value":-187,"profit":false},{"date":"2025-09-30","value":-131,"profit":false}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Revenue	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Cost of Revenue	-	162.16%	417.06%	(92.73%)	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":38.88,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-22.23,"profit":false},{"date":"2025-09-30","value":"-","profit":true}]
Gross Profit	-	(362.16%)	(617.06%)	(92.73%)	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":"-","profit":true}]
Gross Margin	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]

Operating Expenses	-	73.92%	(8.32%)	(4.80%)	(26.80%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-11.26,"profit":false},{"date":"2025-06-30","value":-6.49,"profit":false},{"date":"2025-09-30","value":-36.26,"profit":false}]
Operating Income	-	73.92%	(8.19%)	(4.93%)	(26.79%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-11.08,"profit":false},{"date":"2025-06-30","value":-6.67,"profit":false},{"date":"2025-09-30","value":-36.24,"profit":false}]
Total Non-Operating Income/Expense	-	74.87%	(9.39%)	(18.88%)	(28.22%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-12.55,"profit":false},{"date":"2025-06-30","value":-25.21,"profit":false},{"date":"2025-09-30","value":-37.69,"profit":false}]
Pre-Tax Income	-	73.90%	(8.16%)	(4.63%)	(26.77%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-11.05,"profit":false},{"date":"2025-06-30","value":-6.27,"profit":false},{"date":"2025-09-30","value":-36.22,"profit":false}]
Income Taxes	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Income After Taxes	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]

Income From Continuous Operations	-	73.90%	(8.16%)	(4.63%)	(26.77%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-11.05,"profit":false},{"date":"2025-06-30","value":-6.27,"profit":false},{"date":"2025-09-30","value":-36.22,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Net Income	-	73.90%	(8.16%)	(4.63%)	(26.77%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-11.05,"profit":false},{"date":"2025-06-30","value":-6.27,"profit":false},{"date":"2025-09-30","value":-36.22,"profit":false}]

EPS (Diluted)	-	16.97%	(18.04%)	(10.53%)	(29.95%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-106.29,"profit":false},{"date":"2025-06-30","value":-62.02,"profit":false},{"date":"2025-09-30","value":-176.44,"profit":false}]

	Dec '22	Dec '23	Dec '24
Total Assets
Current Assets	727.60K	8.49M	10.11M	[{"date":"2022-12-31","value":7.19,"profit":true},{"date":"2023-12-31","value":83.97,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Non-current Assets	50.58K	27.08K	10.74K	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":53.54,"profit":true},{"date":"2024-12-31","value":21.23,"profit":true}]
Total Assets	778.17K	8.52M	10.12M	[{"date":"2022-12-31","value":7.69,"profit":true},{"date":"2023-12-31","value":84.15,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Total Liabilities
Current Liabilities	1.33M	826.88K	2.68M	[{"date":"2022-12-31","value":49.72,"profit":true},{"date":"2023-12-31","value":30.81,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Non-current Liabilities	4.99M	-	-	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Total Liabilities	6.33M	826.88K	2.68M	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":13.06,"profit":true},{"date":"2024-12-31","value":42.41,"profit":true}]

Total Shareholders' equity
Common Stock	8.19K	13.02K	1.78K	[{"date":"2022-12-31","value":62.92,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":13.68,"profit":true}]
Retained Earnings	(6.71M)	(15.07M)	(25.72M)	[{"date":"2022-12-31","value":-671432900,"profit":false},{"date":"2023-12-31","value":-1507141500,"profit":false},{"date":"2024-12-31","value":-2572278300,"profit":false}]
Other Stockholders' Equity	1.15M	22.75M	33.16M	[{"date":"2022-12-31","value":3.48,"profit":true},{"date":"2023-12-31","value":68.61,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Shareholders' equity	(5.55M)	7.69M	7.44M	[{"date":"2022-12-31","value":-72.16,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":96.71,"profit":true}]

Total Liabilities & Shareholders Equity	778.17K	8.52M	10.12M	[{"date":"2022-12-31","value":7.69,"profit":true},{"date":"2023-12-31","value":84.15,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

	Dec '22	Dec '23	Dec '24
Total Assets
Current Assets	-	1067.15%	19.08%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":1.79,"profit":true}]
Non-current Assets	-	(46.46%)	(60.35%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-12-31","value":null,"profit":false}]
Total Assets	-	994.77%	18.83%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":1.89,"profit":true}]

Total Liabilities
Current Liabilities	-	(38.04%)	224.59%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":-16.94,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Non-current Liabilities	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Total Liabilities	-	(86.94%)	224.59%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":-38.71,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	-	58.92%	(86.32%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-146.49,"profit":false}]
Retained Earnings	-	124.47%	70.67%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":56.78,"profit":true}]
Other Stockholders' Equity	-	1869.79%	45.76%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":2.45,"profit":true}]
Total Shareholders' equity	-	(238.57%)	(3.29%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-12-31","value":null,"profit":false}]

Total Liabilities & Shareholders Equity	-	994.77%	18.83%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":1.89,"profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Assets
Current Assets	4.67M	10.11M	7.94M	5.97M	4.08M	[{"date":"2024-09-30","value":46.2,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":78.56,"profit":true},{"date":"2025-06-30","value":59.05,"profit":true},{"date":"2025-09-30","value":40.34,"profit":true}]
Non-current Assets	6.80K	10.74K	8.47K	6.44K	7.90K	[{"date":"2024-09-30","value":63.37,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":78.89,"profit":true},{"date":"2025-06-30","value":60.02,"profit":true},{"date":"2025-09-30","value":73.55,"profit":true}]
Total Assets	4.68M	10.12M	7.95M	5.98M	4.09M	[{"date":"2024-09-30","value":46.22,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":78.56,"profit":true},{"date":"2025-06-30","value":59.05,"profit":true},{"date":"2025-09-30","value":40.38,"profit":true}]

Total Liabilities
Current Liabilities	1.27M	2.68M	1.84M	1.68M	1.35M	[{"date":"2024-09-30","value":47.2,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":68.56,"profit":true},{"date":"2025-06-30","value":62.58,"profit":true},{"date":"2025-09-30","value":50.4,"profit":true}]
Non-current Liabilities	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Total Liabilities	1.27M	2.68M	1.84M	1.68M	1.35M	[{"date":"2024-09-30","value":47.2,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":68.56,"profit":true},{"date":"2025-06-30","value":62.58,"profit":true},{"date":"2025-09-30","value":50.4,"profit":true}]

Total Shareholders' equity
Common Stock	1.23K	1.78K	1.91K	2.01K	2.06K	[{"date":"2024-09-30","value":59.93,"profit":true},{"date":"2024-12-31","value":86.55,"profit":true},{"date":"2025-03-31","value":92.71,"profit":true},{"date":"2025-06-30","value":97.43,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Retained Earnings	(21.54M)	(25.72M)	(29.57M)	(33.24M)	(35.92M)	[{"date":"2024-09-30","value":-2153551400,"profit":false},{"date":"2024-12-31","value":-2572278300,"profit":false},{"date":"2025-03-31","value":-2956816300,"profit":false},{"date":"2025-06-30","value":-3323545000,"profit":false},{"date":"2025-09-30","value":-3592115500,"profit":false}]
Other Stockholders' Equity	24.95M	33.16M	35.68M	37.53M	38.65M	[{"date":"2024-09-30","value":64.54,"profit":true},{"date":"2024-12-31","value":85.79,"profit":true},{"date":"2025-03-31","value":92.3,"profit":true},{"date":"2025-06-30","value":97.1,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Total Shareholders' equity	3.41M	7.44M	6.11M	4.30M	2.73M	[{"date":"2024-09-30","value":45.87,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":82.17,"profit":true},{"date":"2025-06-30","value":57.78,"profit":true},{"date":"2025-09-30","value":36.76,"profit":true}]

Total Liabilities & Shareholders Equity	4.68M	10.12M	7.95M	5.98M	4.09M	[{"date":"2024-09-30","value":46.22,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":78.56,"profit":true},{"date":"2025-06-30","value":59.05,"profit":true},{"date":"2025-09-30","value":40.38,"profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Assets
Current Assets	-	116.43%	(21.44%)	(24.83%)	(31.69%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-18.41,"profit":false},{"date":"2025-06-30","value":-21.33,"profit":false},{"date":"2025-09-30","value":-27.21,"profit":false}]
Non-current Assets	-	57.81%	(21.11%)	(23.92%)	22.53%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-36.51,"profit":false},{"date":"2025-06-30","value":-41.37,"profit":false},{"date":"2025-09-30","value":38.98,"profit":true}]
Total Assets	-	116.35%	(21.44%)	(24.83%)	(31.63%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-18.43,"profit":false},{"date":"2025-06-30","value":-21.34,"profit":false},{"date":"2025-09-30","value":-27.18,"profit":false}]

Total Liabilities
Current Liabilities	-	111.85%	(31.44%)	(8.73%)	(19.46%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-28.11,"profit":false},{"date":"2025-06-30","value":-7.81,"profit":false},{"date":"2025-09-30","value":-17.4,"profit":false}]
Non-current Liabilities	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Total Liabilities	-	111.85%	(31.44%)	(8.73%)	(19.46%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-28.11,"profit":false},{"date":"2025-06-30","value":-7.81,"profit":false},{"date":"2025-09-30","value":-17.4,"profit":false}]

Total Shareholders' equity
Common Stock	-	44.41%	7.13%	5.08%	2.64%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":16.05,"profit":true},{"date":"2025-06-30","value":11.44,"profit":true},{"date":"2025-09-30","value":5.95,"profit":true}]
Retained Earnings	-	19.44%	14.95%	12.40%	8.08%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":76.89,"profit":true},{"date":"2025-06-30","value":63.79,"profit":true},{"date":"2025-09-30","value":41.56,"profit":true}]
Other Stockholders' Equity	-	32.93%	7.60%	5.19%	2.99%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":23.07,"profit":true},{"date":"2025-06-30","value":15.77,"profit":true},{"date":"2025-09-30","value":9.08,"profit":true}]
Total Shareholders' equity	-	118.02%	(17.83%)	(29.68%)	(36.38%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-15.11,"profit":false},{"date":"2025-06-30","value":-25.15,"profit":false},{"date":"2025-09-30","value":-30.83,"profit":false}]

Total Liabilities & Shareholders Equity	-	116.35%	(21.44%)	(24.83%)	(31.63%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-18.43,"profit":false},{"date":"2025-06-30","value":-21.34,"profit":false},{"date":"2025-09-30","value":-27.18,"profit":false}]

	Dec '22	Dec '23	Dec '24
Operating Activities
Net Operating Cash Flow	(1.20M)	(3.53M)	(7.36M)	[{"date":"2022-12-31","value":-120477000,"profit":false},{"date":"2023-12-31","value":-353032300,"profit":false},{"date":"2024-12-31","value":-735755000,"profit":false}]

Investing Activities
Net Investing Cash Flow	(2.28K)	(3.25K)	(6.54K)	[{"date":"2022-12-31","value":-227900,"profit":false},{"date":"2023-12-31","value":-325400,"profit":false},{"date":"2024-12-31","value":-653700,"profit":false}]

Financing Activities
Net Financing Cash Flow	1.24M	11.90M	8.98M	[{"date":"2022-12-31","value":10.41,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":75.44,"profit":true}]

Net Change in Cash	32.59K	8.37M	1.62M	[{"date":"2022-12-31","value":0.39,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":19.3,"profit":true}]

Free Cash Flow
Free Cash Flow	(1.21M)	(3.53M)	(7.36M)	[{"date":"2022-12-31","value":-120725600,"profit":false},{"date":"2023-12-31","value":-353357700,"profit":false},{"date":"2024-12-31","value":-736408700,"profit":false}]

	Dec '22	Dec '23	Dec '24
Operating Activities
Net Operating Cash Flow	-	193.03%	108.41%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":56.16,"profit":true}]

Investing Activities
Net Investing Cash Flow	-	42.78%	100.89%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":42.4,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Financing Activities
Net Financing Cash Flow	-	860.24%	(24.56%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-2.86,"profit":false}]

Net Change in Cash	-	25586.40%	(80.70%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-0.32,"profit":false}]

Free Cash Flow
Free Cash Flow	-	192.69%	108.40%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":56.26,"profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Operating Activities
Net Operating Cash Flow	(2.20M)	(1.79M)	(4.65M)	(3.03M)	(2.36M)	[{"date":"2024-09-30","value":-220122000,"profit":false},{"date":"2024-12-31","value":-179070600,"profit":false},{"date":"2025-03-31","value":-464875500,"profit":false},{"date":"2025-06-30","value":-302580200,"profit":false},{"date":"2025-09-30","value":-235715000,"profit":false}]

Investing Activities
Net Investing Cash Flow	-	(6.54K)	(3.25K)	3.25K	(1.85K)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-201.08,"profit":false},{"date":"2025-03-31","value":-100,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-57,"profit":false}]

Financing Activities
Net Financing Cash Flow	1.53M	7.45M	1.97M	1.26M	648.36K	[{"date":"2024-09-30","value":20.51,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":26.44,"profit":true},{"date":"2025-06-30","value":16.92,"profit":true},{"date":"2025-09-30","value":8.7,"profit":true}]

Net Change in Cash	(673.27K)	5.65M	(2.68M)	(1.77M)	(1.71M)	[{"date":"2024-09-30","value":-11.91,"profit":false},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-47.43,"profit":false},{"date":"2025-06-30","value":-31.22,"profit":false},{"date":"2025-09-30","value":-30.26,"profit":false}]

Free Cash Flow
Free Cash Flow	(2.20M)	(1.80M)	(4.65M)	(3.03M)	(2.36M)	[{"date":"2024-09-30","value":-220122000,"profit":false},{"date":"2024-12-31","value":-179724300,"profit":false},{"date":"2025-03-31","value":-465201000,"profit":false},{"date":"2025-06-30","value":-302905700,"profit":false},{"date":"2025-09-30","value":-235900000,"profit":false}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Operating Activities
Net Operating Cash Flow	-	(18.65%)	159.60%	(34.91%)	(22.10%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-11.68,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-21.87,"profit":false},{"date":"2025-09-30","value":-13.85,"profit":false}]

Investing Activities
Net Investing Cash Flow	-	-	(50.27%)	(200.00%)	(157.00%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false}]

Financing Activities
Net Financing Cash Flow	-	387.67%	(73.56%)	(36.02%)	(48.56%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-18.98,"profit":false},{"date":"2025-06-30","value":-9.29,"profit":false},{"date":"2025-09-30","value":-12.53,"profit":false}]

Net Change in Cash	-	(939.78%)	(147.43%)	(34.17%)	(3.10%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false}]

Free Cash Flow
Free Cash Flow	-	(18.35%)	158.84%	(34.89%)	(22.12%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-11.55,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-21.96,"profit":false},{"date":"2025-09-30","value":-13.93,"profit":false}]

Cadrenal Therapeutics, Inc. Common Stock Ratios

Cadrenal Therapeutics, Inc. Common Stock Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

	CVKD
Cash Ratio	2.85
Current Ratio	3.02

Cadrenal Therapeutics, Inc. Common Stock Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

	CVKD
ROA (LTM)	-209.23%
ROE (LTM)	-468.03%

Cadrenal Therapeutics, Inc. Common Stock Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

	CVKD
Debt Ratio Lower is generally better. Negative is bad.	0.33
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier.	0.67

Cadrenal Therapeutics, Inc. Common Stock Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

	CVKD
Trailing PE	NM
Forward PE	NM
P/S (TTM)	0.00
P/B	4.94
Price/FCF	NM
EV/R	0.00
EV/Ebitda	0.21

Discover more

Tesla, Inc.

Apple, Inc.

Alphabet Inc. - Class A Shares

Meta Platforms Inc

Amazon.com Inc.

Microsoft Corporation

NVIDIA Corporation

Berkshire Hathaway Inc. Hld B

Eli Lilly and Company

FAQs

What is Cadrenal Therapeutics, Inc. Common Stock share price today?

Cadrenal Therapeutics, Inc. Common Stock (CVKD) share price today is $5.535

Can Indians buy Cadrenal Therapeutics, Inc. Common Stock shares?

Yes, Indians can buy shares of Cadrenal Therapeutics, Inc. Common Stock (CVKD) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in CVKD stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Cadrenal Therapeutics, Inc. Common Stock be purchased?

Yes, you can purchase fractional shares of Cadrenal Therapeutics, Inc. Common Stock (CVKD) via the Vested app. You can start investing in Cadrenal Therapeutics, Inc. Common Stock (CVKD) with a minimum investment of $1.

How to invest in Cadrenal Therapeutics, Inc. Common Stock shares from India?

You can invest in shares of Cadrenal Therapeutics, Inc. Common Stock (CVKD) via Vested in three simple steps:

Click on Sign Up or Invest in CVKD stock at the top of this page
Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
Transfer USD funds to your US Brokerage account and start investing in Cadrenal Therapeutics, Inc. Common Stock shares

What is Cadrenal Therapeutics, Inc. Common Stock 52-week high and low stock price?

The 52-week high price of Cadrenal Therapeutics, Inc. Common Stock (CVKD) is $22.9. The 52-week low price of Cadrenal Therapeutics, Inc. Common Stock (CVKD) is $5.34.

What is Cadrenal Therapeutics, Inc. Common Stock price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Cadrenal Therapeutics, Inc. Common Stock (CVKD) is

What is Cadrenal Therapeutics, Inc. Common Stock price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Cadrenal Therapeutics, Inc. Common Stock (CVKD) is 4.94

What is Cadrenal Therapeutics, Inc. Common Stock dividend yield?

The dividend yield of Cadrenal Therapeutics, Inc. Common Stock (CVKD) is 0.00%

What is the Market Cap of Cadrenal Therapeutics, Inc. Common Stock?

The market capitalization of Cadrenal Therapeutics, Inc. Common Stock (CVKD) is $12.67M

What is Cadrenal Therapeutics, Inc. Common Stock's stock symbol?

The stock symbol (or ticker) of Cadrenal Therapeutics, Inc. Common Stock is CVKD

How Can Investors Use Cadrenal Therapeutics, Inc. Common Stock Share Price Data for Long-Term Investment Decisions?

Consider the share price of Cadrenal Therapeutics, Inc. Common Stock as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Cadrenal Therapeutics, Inc. Common Stock has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Cadrenal Therapeutics, Inc. Common Stock shares for Indian investors?

When investing in Cadrenal Therapeutics, Inc. Common Stock shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Cadrenal Therapeutics, Inc. Common Stock stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Cadrenal Therapeutics, Inc. Common Stock share price with other stocks in the same sector?

Rather than merely checking the share price of Cadrenal Therapeutics, Inc. Common Stock and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Cadrenal Therapeutics, Inc. Common Stock stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Feedback

Request to add more info/data

Inform about wrong info/data

Link copied

Signup to access all features and start your US investing journey!

Open your account in minutes
Take your portfolio global, starting at just $1

Get started

Add ticker to compare

Apple, Inc AAPL
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

US Stocks & ETFs

Private Markets

Managed Portfolios (Previously Vests)

Global Funds

Global

Explore our India Diversification

INR Bonds

Alt FDs

Cadrenal Therapeutics, Inc. Common Stock Share Price

Cadrenal Therapeutics, Inc. Common Stock Analyst Forecast

Cadrenal Therapeutics, Inc. Common Stock Share Price Chart

Cadrenal Therapeutics, Inc. Common Stock Key Stock Metrics

About Cadrenal Therapeutics, Inc. Common Stock, Common Stock

Cadrenal Therapeutics, Inc. Common Stock Stock Returns

Cadrenal Therapeutics, Inc. Common Stock Financials

Cadrenal Therapeutics, Inc. Common Stock Ratios

Cadrenal Therapeutics, Inc. Common Stock Liquidity Ratios

Cadrenal Therapeutics, Inc. Common Stock Asset Efficiency Ratios

Cadrenal Therapeutics, Inc. Common Stock Liability Ratios

Cadrenal Therapeutics, Inc. Common Stock Valuation Ratios

Discover more

FAQs

Feedback

Signup to access all features and start your US investing journey!

Add ticker to compare

Company

Explore Products

Popular US Stocks ¹

Popular US ETFs ²

Curated Portfolios (Vests)

Risk Disclosure - US Markets

US Stocks & ETFs

Private Markets

Managed Portfolios (Previously Vests)

Global Funds

Global

Explore our India Diversification

INR Bonds

Alt FDs

Cadrenal Therapeutics, Inc. Common Stock Share Price

Cadrenal Therapeutics, Inc. Common Stock Analyst Forecast

Cadrenal Therapeutics, Inc. Common Stock Share Price Chart

Cadrenal Therapeutics, Inc. Common Stock Key Stock Metrics

About Cadrenal Therapeutics, Inc. Common Stock, Common Stock

Cadrenal Therapeutics, Inc. Common Stock Stock Returns

Cadrenal Therapeutics, Inc. Common Stock Financials

Cadrenal Therapeutics, Inc. Common Stock Ratios

Cadrenal Therapeutics, Inc. Common Stock Liquidity Ratios

Cadrenal Therapeutics, Inc. Common Stock Asset Efficiency Ratios

Cadrenal Therapeutics, Inc. Common Stock Liability Ratios

Cadrenal Therapeutics, Inc. Common Stock Valuation Ratios

Discover more

FAQs

Feedback

Signup to access all features and start your US investing journey!

Add ticker to compare

Popular US Stocks 1

Popular US ETFs 2

Curated Portfolios (Vests)

Popular US Stocks ¹

Popular US ETFs ²